NASDAQ:ELTX | Profit Breakdown | Elicio Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$10.43M-$8.22M
2026-03-31-$10.6M-$11.82M
2025-12-31-$8.84M-$7.72M
2025-09-30-$8.05M-$10.08M
2025-06-30-$10.09M-$10.56M
2025-03-31-$10.74M-$11.21M
2024-12-31-$13.48M-$14M
2024-09-30-$10.34M-$18.84M
2024-06-30-$10.92M-$7.23M
2024-03-31-$10.24M-$11.83M
2023-12-31-$9.39M-$8.95M
2023-09-30-$10.77M-$10.66M
2023-06-30-$7.78M-$7.56M
2023-03-31$0.00-$7.81M-$8.03M
2022-12-31$0.00-$5.96M-$6.65M
2022-09-30$0.00-$5.77M-$7.2M
2022-06-30$653,000.00-$6.23M-$7.3M
2022-03-31$1.65M-$14.49M-$7.06M
2021-12-31$25.14M$14.63M$14.89M
2021-09-30$1.46M-$15.76M-$15.7M
2021-06-30$540,000.00-$18.24M-$17.07M
2021-03-31$371,000.00-$19.94M-$36.69M
2020-12-31$193,000.00-$13.85M-$28.88M
2020-09-30$0.00-$11.59M-$17.67M
2020-06-30$0.00-$17.27M-$20.34M
2020-03-31$0.00-$12.57M-$13.22M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$37.71M-$39.57M-$39.57M
2024-12-31-$44.99M-$51.9M-$51.9M
2023-12-31-$35.75M-$35.2M
2022-12-31$2.3M-$23.73M-$38.8M-$28.21M
2021-12-31$27.51M-$39.31M-$54.57M-$54.57M
2020-12-31$193,000.00-$55.27M-$80.11M-$80.11M